#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Lung adenocarcinoma Aicardi-Goutieres syndrome Autoimmune myositis Hodgkin's disease refractory Microscopic polyangiitis Thermal burn Acquired C1 inhibitor deficiency Rectal cancer Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Neonatal asphyxia Congenital ectodermal dysplasia Oesophageal atresia Hepatic cirrhosis Hepatitis D Epilepsy More trials…

    Learn about Rare Diseases

    Langerhans cell sarcoma Rett syndrome – Basic Information Anaplastic thyroid cancer – Treatment Behcet’s syndrome – Diagnostics Leiomyosarcoma metastatic – Diagnostics Hereditary ataxia – Trials in Disease Pituitary-dependent Cushing’s syndrome Marginal zone lymphoma refractory Leiomyosarcoma recurrent – Treatment Soft tissue sarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mk-0482 Tramadol Alirocumab Vutrisiran Meclofenamate Sodium Inclisiran Efepoetin Alfa Taldefgrobep Alfa CHONDROITIN SULFATE SODIUM PALAZESTRANT Human Fibrinogen THEOPHYLLINE ANHYDROUS Aminohippuric Acid Sacituzumab Tirumotecan Idursulfase Anb032 GSK5460025A Fluindione GXV813 Liraglutide More therapies…

    Learn about Your Condition

    Small cell carcinoma Pulmonary vascular disorder Subdural haematoma Gout VEXAS syndrome Follicular lymphoma Piriformis syndrome Mite allergy Chronic coronary syndrome Embolism Ocular myasthenia Haemoglobinuria Endocarditis bacterial Senile dementia Rectal neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hypercholesterolaemia

  • Triple vs dual therapy with rosuvastatin, ezetimibe and bempedoic acid in patients with atherosclerotic heart disease and high cholesterol undergoing revascularisation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Arteriosclerosis coronary artery
    • Hypercholesterolaemia
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • Rosuvastatin
    • Bempedoic Acid
    • Ezetimibe
    Austria Germany

  • Study of K-924 (ezetimibe and pitavastatin) in patients with high cholesterol who have an inadequate response to pitavastatin

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hypercholesterolaemia
    Investigated Drugs:
    • Ezetimibe
    Spain

  • Study on the Effect of Genetic Testing and Training on Muscle Side Effects in Patients Taking Statins for Cardiovascular Risk Prevention

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Primary hypercholesterolaemia
    • Hypercholesterolaemia
    Investigated Drugs:
    • Fluvastatin Sodium
    • Pitavastatin Calcium
    • Rosuvastatin Zinc
    Spain

  • Laroprovstat/rosuvastatin versus rosuvastatin for lowering LDL‑C in patients with high cholesterol

    Not yet recruiting

    3 1
    Investigated Drugs:
    • Rosuvastatin
    Germany

  • Study on the Effects and Safety of MK-0616 for Adults with High Cholesterol

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Hypercholesterolaemia
    Investigated Drugs:
    • Mk-0616
    Germany Italy Spain

  • Study of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels

    Not recruiting

    3 1
    Investigated Diseases:
    • Hypercholesterolaemia
    Bulgaria Czechia Germany Hungary Poland Slovakia +1
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!